In ₹ Crore except Per Share Latest Annual	APOLLOHOSP FY26	FORTIS FY26	MAXHEALTH FY26	MEDANTA FY26	Peer Average
Valuation — at last close
P/E	60.26×	◆ 55.04×	57.42×	61.95×	58.13× +4%
P/B	12.34×	◆ 5.79×	7.71×	8.70×	7.40× +67%
EV/EBITDA	32.11×	◆ 28.74×	38.18×	37.60×	34.84× -8%
Market Cap	₹1.17L Cr	₹57,339 Cr	₹82,862 Cr	₹34,473 Cr	₹58,225 Cr +101%
Growth
Revenue CAGR 3Y	14.94%	13.17%	◆ 22.43%	17.85%	17.82% -16%
Revenue CAGR 5Y	19.03%	17.76%	◆ 27.30%	—	22.53% -16%
Net Income CAGR 3Y	◆ 33.35%	18.91%	9.34%	19.33%	15.86% +110%
Revenue YoY (latest Q)	20.56%	17.46%	16.70%	◆ 26.50%	20.22% +2%
Net Income YoY (latest Q)	◆ 38.41%	2.26%	4.87%	-1.09%	2.01% +1808%
Profitability
EBITDA Margin	14.94%	22.84%	◆ 26.79%	20.84%	23.49% -36%
Net Income Margin	7.94%	11.66%	◆ 17.23%	12.56%	13.82% -43%
Return on Common Equity	◆ 21.95%	11.08%	14.33%	15.15%	13.52% +62%
Return on Capital Employed	◆ 18.20%	12.62%	12.63%	14.78%	13.34% +36%
Return on Assets	9.35%	7.18%	8.89%	◆ 10.38%	8.82% +6%
Credit & Quality
Total Debt/Equity	0.57×	◆ 0.28×	0.32×	0.30×	0.30× +90%
Interest Coverage	6.44×	5.20×	7.64×	◆ 8.80×	7.21× -11%
Scale — latest FY
Revenue / Total Income	₹25,229 Cr	₹9,128 Cr	₹8,373 Cr	₹4,410 Cr	₹7,304 Cr +245%
Net Income	₹2,003 Cr	₹1,064 Cr	₹1,442 Cr	₹554 Cr	₹1,020 Cr +96%
Total Assets	₹22,197 Cr	₹15,966 Cr	₹17,231 Cr	₹5,905 Cr	₹13,034 Cr +70%
EPS	₹135.04	₹13.8	₹14.83	₹20.71	₹16.45 +721%
Book Value per Share	₹659.26	₹131.07	₹110.43	₹147.44	₹129.65 +409%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 145%.